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Background/aim: To determine whether there was a difference between serum and hair trace elements’ concentrations in patients with
Alzheimer disease (AD) and healthy participants.
Materials and methods: Hair and serum copper, selenium, zinc, magnesium, manganese, and iron levels were measured by inductively
coupled plasma-mass spectrometry in patients with AD and healthy participants, and the obtained results were statistically compared.
Results: The mean hair selenium and zinc levels of patients with AD were significantly lower than the levels found for control
participants (P < 0.05). Patients with AD had significantly higher mean hair copper and manganese levels than the controls. There
were no significant differences between AD patients and controls with respect to the hair iron and magnesium levels (P > 0.05). Hair
and serum trace element (copper, selenium, zinc, magnesium, manganese, and iron) levels in patients with AD showed no significant
difference according to mini mental test scores or sex (P > 0.05).
Conclusion: Some trace element levels may change in patients with AD. Due to the more permanent status, the analysis of these element
levels in hair might be superior to blood analysis.
Key words: Alzheimer disease, trace element, hair, serum

1. Introduction
Trace elements play an important role in numerous
metabolic processes, and they are known to be essential
for the activity of some enzymes. Their homeostasis
is managed tightly by cells, and any disturbance leads
to severe consequences. Alzheimer disease (AD) is
a multifactorial disease in which several genetic and
environmental factors have been implicated. Amyloid-β
(Aβ) is a major constituent of senile plaques and one of
the principal hallmarks of AD. Increased production and
aggregation of the Aβ peptide is associated with disease
pathology. Recent studies have emphasized not only that
the etiology of AD involves Aβ aggregation, but also
that metal ions contribute to this process by activating
or inhibiting enzymatic reactions, by increasing reactive
oxygen species (ROS), by competing with other elements,
and by affecting the permeability of cell membranes (1,2).
* Correspondence: erabiakoc@yahoo.com
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An imbalance of trace elements in the human body
might be a possible indicative factor for AD. Therefore, it
is important to detect metal dyshomeostasis that occurs
with AD, as it could offer possibilities for effective and
novel therapeutic approaches. Although many authors
have studied the relationship between some trace elements
and AD, there are conflicting reports in the literature
on this issue. Some researchers have suggested that low
trace element levels contribute to the pathogenesis of
AD, while others have proposed that elevated element
levels are responsible for this process (2–5). However,
all of these studies emphasized that patients with AD
might show some abnormalities in serum and brain trace
element concentrations (1,6–8). It has been proposed that
scalp hair should be used to determine systemic levels
of elements, rather than other types of samples. Trace
element levels tend to be higher in hair than in sera, and
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serum element levels can vary widely within a given day,
depending on food intake. Stable tissues (e.g., hair or nail)
should be used to obtain permanent results due to their
slow metabolic turnover rates. Based on these facts, we
studied trace element levels in hair of AD patients and
compared them with those of controls.
2. Materials and methods
The present study was designed as a hospital-based casecontrol study. It was approved by the Ethics Committee of
the Faculty of Medicine of Turgut Özal University.
2.1. Participants
A total of 45 patients diagnosed with AD (22 women and
23 men; average age of 77.66 ± 9.28 years) and 33 healthy
participants (17 women and 16 men; average age of 73.18
± 10.61 years) were examined. The AD patients met the
diagnostic criteria of probable AD, according to the
established criteria (National Institute of Neurological and
Communicative Disorders and Stroke and the Alzheimer’s
Disease and Related Disorders Association (NINDSADRDA) and Diagnostic and Statistical Manual of Mental
Disorders, 4th edition) (9,10). The Turkish version of the
Mini Mental State Examination (MMSE) was used to
screen for cognitive impairment (11). Since geographic
and environmental conditions may affect the hair and
blood levels of trace elements, patients had to have lived
in Ankara for at least 1 year. Hair samples were obtained
from people who did not have colored or treated hair.
Patients who had diabetes, kidney failure, inflammatory
disease, or malignancy were excluded. Additionally,
those who were receiving polytherapy were excluded. The
exclusion criteria for the patients were also applied to the
controls. Informed consent was obtained from all patients
and healthy participants. For those patients who were
incapable of providing informed consent, it was obtained
from relatives.
2.2. Blood samples
Blood samples were taken in the morning (0930 hours)
from the patients and controls after approximately 12 h of
fasting (before breakfast).Venous blood (10 mL) was taken
from the patients and controls without using anticoagulant,
and samples were centrifuged at 3000 × g for 15 min at
room temperature. Serum samples were stored at –80 °C
for the measurement of trace elements.
2.3. Hair samples
Hair specimens were taken on the same day as blood
sampling. Eighty-eight hair samples, weighing about 2 g,
were taken from the nape of the head as near as possible
to the scalp with Teflon scissors and stored in polyethylene
bags. The scissors were cleaned after each sampling.

2.4. Elemental analysis by ICP/MS
The hair samples were prepared according to the modified
method developed by the International Atomic Energy
Agency (12). The hair specimen was cut and washed
in deionized water. The samples were then rinsed with
acetone and allowed to dry in an oven at 40–70 °C. After
drying, the hair samples were digested, weighing each
sample (25–200 mg) in a microwave (Speedwave, Berghof)
in digestion Teflon bottles with 5 mL of nitric acid. Serum
samples (0.5–1.5 mL) were also digested with 5 mL of
nitric acid in the same way. The microwave parameters are
given in Table 1. After digestion, the samples were diluted
with deionized water containing 1% nitric acid. The final
volume was 10–50 mL and 10–30 mL for hair and serum
samples, respectively. The resulting product was a clear
liquid with a yellow tint. A PerkinElmer Elan 9000 ICPMS (Waltham, MA, USA ) was used to analyze the samples
in a private laboratory.
The performance of the instrument was checked daily
with Nexion Setup Solution 1% nitric acid (PerkinElmer
Pure Plus). The tuning and response factor criteria were
>20,000 cps for Mg24, >50,000 cps for In115, >40,000 cps
for U238, background 220 < 1 cps, CeO/Ce 156/140 <
2.5%, and Ce++/Ce+ 70/140 < 3%. All these parameters
were obtained before analyzing the samples.
High purity grade reagents were used. For the
preparation of calibrators and samples, 18 M cm–1 MilliQTM DI water (Water Purification System, Human
Power I) and nitric acid (Suprapur 65%, Merck) were
used. Multielement aqueous certified reference material
solutions were used for the calibration curve with the
standards of 1, 5, 20, 50, 80, and 100 ng/mL for zinc (Zn),
copper (Cu), iron (Fe), selenium (Se), and manganese (Mn)
and 50, 200, 500, and 800 ng/mL for magnesium (Mg).
The correlation coefficient from the initial calibration
was ≥0.9988 for each element. A method blank, reagent
water acidified with the same acid concentrations present
in the standards and samples, was used to determine the
concentrations of elements in the reagents used to prepare
and analyze the samples as well as the contribution of
contamination from the digestion process. The detection
limits were calculated from blank standard deviations
(Table 1). Indium, germanium, and scandium were used
as internal standards. Results are reported as µg/g or µg/
mL for elements in hair and serum samples.
2.5. Statistical analysis
Data were analyzed using SPSS for Windows. The data
were first tested using the Shapiro–Wilk test for their
distribution. Normally distributed data were analyzed
using the Student t-test and data were expressed as mean
± SD. The Mann–Whitney U test was used for data found
not to be normally distributed. The results were given as
median (min–max) values. A P-value of less than 0.05 was
regarded as statistically significant.
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Table 1. Detection limits of elements.
Element

Mass

Mode

Detection limits (ppb)

Cu

63

STD

0.03

Fe

57

STD

0.3

Mg

24

STD

0.13

Mn

55

STD

0.04

Se

82

STD

0.05

Zn

66

STD

0.12

3. Results
The results are shown in Table 2. Between groups, there
were no differences with respect to the serum levels of Zn,
Se, Cu, Fe, and Mg (P > 0.05), while Mn was significantly
different (P < 0.05).

The mean hair Se and Zn levels of patients with AD
were significantly lower than the levels found for control
participants (P < 0.05). Patients with AD had mean hair
Cu and Mn levels significantly higher than those found in
the controls. There were no significant differences between

Table 2. Hair and serum trace element levels in patients with AD and controls.
Age (years)
Cu-hair (µg/g)
Cu-serum (µg/mL)
Se-hair (µg/g)
Se-serum (µg/mL)
Zn-hair (µg/g)
Zn-serum(µg/mL)
Mn-hair (µg/g)
Mn-serum (µg/mL)
Fe-hair(µg/g)
Fe-serum (µg/mL)
Mg-hair (µg/g)
Mg-serum (µg/mL)

Groups

N

Mean ± SD

P

Patients

41

77.69 ± 9.29

0.055*

Control

33

73.18 ± 10.61

Patients

41

12.8 ± 4.8

Control

31

10.3 ± 2.4

Patients

44

0.9 (0.4–1.3)

Control

32

1.01 (0.5–1.5)

Patients

37

0.5 ± 0.1

Control

31

0.6 ± 0.1

Patients

40

0.75 ± 0.2

Control

33

0.83 ± 0.4

Patients

41

75 ± 29

Control

33

98 ± 54

Patients

44

0.47 ± 0.1

Control

33

0.52 ± 0.3

Patients

41

0.6 ± 0.3

Control

33

0.4 ± 0.2

Patients

44

0.009 (0–0.03)

Control

33

0.01 (0.01–0.03)

Patients

41

24.6 (8.27–121.5)

Control

33

24.3 (11.4–250)

Patients

44

1.43 (0.5–7)

Control

33

1.5 (0.6–8.3)

Patients

41

39 (12–238)

Control

33

49 (10–640)

Patients

44

17.3 (6.3–23)

Control

33

16.01 (11–56)

*: P-values that resulted from independent sample t-test (mean ± SD)
**: P-values that resulted from the Mann–Whitney U test (median (min–max)).
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0.013*
0.1**
0.005*
0.3*
0.02*
0.4*
0.009*
0.002**
0.8**
0.2**
0.5**
0.6**
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AD patients and control participants with respect to the
hair Fe and Mg levels (P > 0.05). Hair and serum trace
element (Cu, Se, Zn, Mg, Mn, and Fe) levels in patients
with AD showed no significant difference according to
MMSE scores or sex (P > 0.05).
4. Discussion
In this study, we compared hair and serum Cu, Se, Zn,
Mg, Mn, and Fe levels of patients with AD and healthy
participants in order to investigate the relationships between
trace elements and AD. Hair and nail tissues, which have
slow metabolic turnover rates, are an important source
of knowledge regarding the accumulation of elements
over a long period, and they are particularly necessary
for retrospective research (13). Serum is not suitable for
determining the levels of some trace elements, as serum
element levels vary widely within a given day, depending
on food intake (14). Moreover, hair is easily sampled and it
can be preserved indefinitely under appropriate conditions
without deteriorating. Therefore, compared to other types
of clinical specimens, hair samples are more valuable than
blood, serum, urine, or other samples. In the current
study, there were no differences between the two groups in
terms of serum trace element levels, with the exception of
Mn. However, hair trace element levels differed somewhat
between the two groups.
AD is a multifactorial disorder; metal dyshomeostasis
and oxidative stress contribute to the pathogenesis
of neurodegenerative process (15,16). Abnormal
aggregations of different metals elicit oxidative stress and
result in neuronal damage (17,18). Se, an essential mineral,
plays a major role in cellular redox status. Selenoproteins
constitute one of the most important classes of antioxidant
enzymes, the glutathione peroxidases (GPx). GPx requires
Se for its catalytic activity (19,20). Previous reports on
serum or cerebrospinal fluid (CSF) Se concentrations
in AD patients have produced controversial results.
Loef et al. found negative correlations between disease
progression and Se levels (21), while Meseguer et al. found
no differences between AD patient and control groups in
terms of CSF and serum Se levels (22). In our study, hair Se
levels were found to be significantly lower in patients with
AD. The reduced Se concentrations might cause decreased
GPx activity and support the possible role of oxidative
stress, resulting in neurodegeneration, in the pathogenesis
of AD.
Zinc plays an important role in cellular metabolism,
such as proliferation, differentiation, and apoptosis. It
is also necessary for axonal transmission and synaptic
signaling pathways. Zinc is an antioxidant element and
protects tissues against oxidative stress (23,24). Conflicting
results were also found in studies evaluating serum Zn
levels in individuals with and without AD. For example,

Haines et al. reported no significant differences in Zn
levels between patients with AD and controls (25), while
previous brain tissue studies showed significantly lower
Zn levels in patients with AD compared with controls
(26). Similarly, postmortem studies of hippocampus tissue
have shown decreased levels of Zn and Se in participants
with AD compared with controls (27). On the other hand,
animal studies have shown that oral intake of Zn did not
accelerate AD pathology in transgenic and nontransgenic
mice (28,29). In the present study, we found no significant
difference between the serum Zn levels of the two groups,
but the AD group displayed lower mean hair serum Zn
levels. Decreased hair Zn levels in AD patients might
be responsible for decreased antioxidant capacity and
cognitive decline.
Cu is a component of several enzymes and proteins,
including superoxide dismutase (SOD), cytochrome c
oxidase, and ceruloplasmin. It is also a cofactor of Cu/
Zn-SOD, which plays an important role in the antioxidant
defense system. Cu deficiency decreases this enzyme’s
activity (2). In our study, mean hair Cu levels were found
to be significantly higher in patients with AD compared
with healthy controls. Increased Cu concentration might
also be responsible for the AD etiology. Amyloid plaques,
a hallmark of AD, consist of Aβ, which is derived from
the amyloid precursor protein, which has binding Cu (8).
While Aβ aggregation in the presence of Cu can trigger
ROS and consume neuronal glutathione levels, the adult
nervous system can also be damaged by Cu deficiency.
Several clinical manifestations of Cu deficiency have been
described, such as myelopathy, spastic gait, and sensory
ataxia, and Cu therapy sometimes improves neurological
deficits (2). Cu deficiency may reflect decreased enzyme
activity, which can lead to free radical-mediated oxidative
damage. Thus, both increased and decreased Cu levels
might be responsible for ROS-mediated neural damage in
AD patients.
To our knowledge, no prior report on hair Fe levels
in patients with AD exists in the literature. Fe is an
essential element for maintaining the normal structure
and functions of the central nervous system. Neurons and
glial cells require Fe for electron transport, for myelination
of axons, and as a cofactor for enzymes involved in the
synthesis of neurotransmitters (30). Previous studies on
serum, plasma, and brain concentrations of Fe in AD
patients have reported contradictory results (31–34). The
effects of decrease in the bioavailability of Fe in the brain
have been shown to affect neurotransmitter production,
memory, and cognitive function (35). However, excess Fe
accumulation generates cellular damage (36). In our study,
there were no differences in serum or hair Fe levels between
the groups. This result might be due to insufficient food
intake or intestinal malabsorption associated with aging.
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Human cells possess enzymatic antioxidant defenses
to cope with oxygen free radicals. One example is
mitochondrial manganese superoxide dismutase (MnSOD), which catalyzes the dismutation of superoxide
anions to hydrogen peroxide (37). Mn-SOD was localized
by immunocytochemistry in the cerebral cortex and
hippocampus of patients with AD. In one study, the
Mn-SOD scavenger system was found to be associated
with the formation of senile plaques (38). Markesbery et
al. measured Mn levels in various brain regions in AD
patients and aging individuals using instrumental neutron
activation analysis. They found that the differences were
not statistically significant for all regions, but the highest
Mn levels were found in the basal ganglia in both the
controls and the AD patients (39). In a previous study,
CSF concentrations of V, Mn, Rb, Sb, Cs, and Pb were
significantly lower in patients with AD (N = 264; P ≤ 0.007)
than in healthy controls (40). In the current study, hair Mn
levels were found to be significantly higher in patients with
AD than in the control group. Increased Mn levels may be
related to the increased Mn-SOD activity and antioxidant
demand of AD patients.
Altered concentrations of hair trace elements might
be related to the maintenance of the oxidant/antioxidant

balance of the affected tissue. We did not measure
antioxidant status (e.g., SOD, catalase, GPx) in the present
study. It would be very interesting to evaluate both element
concentrations and antioxidant activity in patients with
AD in future studies.
In conclusion, our results demonstrate that some trace
elements, especially hair levels of Cu, Se, Mn, and Zn, can
change in AD patients. These alterations might suggest a
potential role of trace elements in the etiopathogenesis of
AD. Previous study results have shown variations in serum
trace element levels in AD patients, and we found some
differences in hair and serum trace element concentrations
between patients with AD and healthy participants. These
results suggest that hair trace element levels might supply
more accurate trace element level information in AD
patients. Normalization of these elements may be critical
to the development of preventive and therapeutic strategies
for AD. Future evaluation will be useful in understanding
the exact roles of trace elements in the etiopathogenesis
of AD.
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